|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/4545 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 2751094 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12756693.3 |
| Date of filing the European patent application | 2012-08-31 | |
| (97) | Date of publication of the European application | 2014-07-09 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-20 |
| (46) | Date of publication of the claims translation | 2018-11-12 |
| (86) | Number | PCT/EP2012/067027 |
| Date | 2012-08-31 |
| (87) | Number | WO 2013/030374 |
| Date | 2013-03-07 |
| (30) | Number | Date | Country code |
| 201161530104 P | 2011-09-01 | US |
| (72) |
LEE, Mei-yin, GB
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujoji kristalinė forma |
| NOVEL CRYSTAL FORM |
| Payment date | Validity (years) | Amount | |
| 2019-08-12 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-08-31 |